These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11850055)

  • 1. Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia.
    Ohtsuki T; Watanabe H; Toru M; Arinami T
    Psychiatry Res; 2002 Jan; 109(1):93-6. PubMed ID: 11850055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma.
    Ito S; Noguchi E; Shibasaki M; Yamakawa-Kobayashi K; Watanabe H; Arinami T
    J Hum Genet; 2002; 47(2):99-101. PubMed ID: 11916011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.
    Kruse S; Mao XQ; Heinzmann A; Blattmann S; Roberts MH; Braun S; Gao PS; Forster J; Kuehr J; Hopkin JM; Shirakawa T; Deichmann KA
    Am J Hum Genet; 2000 May; 66(5):1522-30. PubMed ID: 10733466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells.
    Yoshida H; Satoh K; Koyama M; Hiramoto M; Takamatsu S
    Am J Hematol; 1996 Nov; 53(3):158-64. PubMed ID: 8895685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy.
    Tanaka R; Iijima K; Xu H; Inoue Y; Murakami R; Shirakawa T; Nishiyama K; Miwa M; Shiozawa S; Nakamura H; Yoshikawa N
    Am J Kidney Dis; 1999 Aug; 34(2):289-95. PubMed ID: 10430976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome.
    Xu H; Iijima K; Shirakawa T; Shiozawa S; Miwa M; Yamaoka K; Kawamura N; Nakamura H; Yoshikawa N
    Am J Kidney Dis; 2000 Jul; 36(1):42-6. PubMed ID: 10873870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma.
    Satoh N; Asano K; Naoki K; Fukunaga K; Iwata M; Kanazawa M; Yamaguchi K
    Am J Respir Crit Care Med; 1999 Mar; 159(3):974-9. PubMed ID: 10051281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the existence of the PAF acetylhydrolase mutation (Val279Phe) in non-Japanese populations: a preliminary study in Turkey, Azerbaijan, and Kyrgyzstan.
    Balta G; Gurgey A; Kudayarov DK; Tunc B; Altay C
    Thromb Res; 2001 Feb; 101(4):231-4. PubMed ID: 11248283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
    Stafforini DM; Satoh K; Atkinson DL; Tjoelker LW; Eberhardt C; Yoshida H; Imaizumi T; Takamatsu S; Zimmerman GA; McIntyre TM; Gray PW; Prescott SM
    J Clin Invest; 1996 Jun; 97(12):2784-91. PubMed ID: 8675689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.
    Hiramoto M; Yoshida H; Imaizumi T; Yoshimizu N; Satoh K
    Stroke; 1997 Dec; 28(12):2417-20. PubMed ID: 9412624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.
    Yamada Y; Ichihara S; Fujimura T; Yokota M
    Metabolism; 1998 Feb; 47(2):177-81. PubMed ID: 9472966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor acetylhydrolase gene mutation in Japanese nephrotic children.
    Xu H; Iijima K; Shiozawa S; Tanaka SS; Inoue Y; Shirakawa T; Nishiyama K; Miwa M; Nakamura H; Yoshikawa N
    Kidney Int; 1998 Dec; 54(6):1867-71. PubMed ID: 9853251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan.
    Unno N; Nakamura T; Kaneko H; Uchiyama T; Yamamoto N; Sugatani J; Miwa M; Nakamura S
    J Vasc Surg; 2000 Aug; 32(2):263-7. PubMed ID: 10917985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.
    Yamada Y; Yoshida H; Ichihara S; Imaizumi T; Satoh K; Yokota M
    Atherosclerosis; 2000 May; 150(1):209-16. PubMed ID: 10781653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension.
    Yoshida H; Imaizumi T; Fujimoto K; Itaya H; Hiramoto M; Yoshimizu N; Fukushi K; Satoh K
    Thromb Haemost; 1998 Sep; 80(3):372-5. PubMed ID: 9759612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma.
    Tsukioka K; Matsuzaki M; Nakamata M; Kayahara H; Nakagawa T
    J Investig Allergol Clin Immunol; 1996; 6(1):22-9. PubMed ID: 8833165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.
    Stafforini DM; Numao T; Tsodikov A; Vaitkus D; Fukuda T; Watanabe N; Fueki N; McIntyre TM; Zimmerman GA; Makino S; Prescott SM
    J Clin Invest; 1999 Apr; 103(7):989-97. PubMed ID: 10194471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a G994-->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese.
    Ichihara S; Yamada Y; Yokota M
    Circulation; 1998 Nov; 98(18):1881-5. PubMed ID: 9799208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.
    Li S; Stuart L; Zhang Y; Meduri GU; Umberger R; Yates CR
    J Clin Pharm Ther; 2009 Aug; 34(4):447-55. PubMed ID: 19583678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma].
    Tsukioka K; Matsuzaki M; Nakamata M; Kayahara H
    Arerugi; 1993 Feb; 42(2):167-71. PubMed ID: 8507159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.